ema tirzepatide probes suicide risk with Novo Nordisk obesity drugs EMA outlines methods for evaluating

The Wrap What else were following At home: The Vancouver Symphony Orchestra said it will no longer ask sexual-misconduct complainants to sign non-disclosure agreements

Early initiation of oral semaglutide, particularly in drug-nave individuals, can significantly improve glycemic control, reduce body weight, and manage CV risk factors, offering an opportunity to alter the trajectory of diabetes progression

Bay Area biotech Excellergy just raised $70M to advance a new class of trifunctional drugs that take on allergic reactions from multiple angles going beyond what todays treatments like Xolair can do

Supporting weight loss

Gastroenterologists typically assess fecal calprotectin, endoscopic findings, and symptom severity to establish a clear baseline